blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3102184

EP3102184 - STABLE PEPTIDE FORMULATIONS AND METHODS FOR PREPARATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.12.2019
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  30.12.2018
FormerGrant of patent is intended
Status updated on  09.09.2018
FormerExamination is in progress
Status updated on  09.03.2018
FormerRequest for examination was made
Status updated on  11.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Xeris Pharmaceuticals, Inc.
180 N. LaSalle Street, Suite 1600
Chicago, IL 60601 / US
[2019/33]
Former [2016/50]For all designated states
Xeris Pharmaceuticals, Inc.
3208 Red River, Suite 300
Austin TX 78705 / US
Inventor(s)01 / PRESTRELSKI, Steven
c/o Xeris Phrmaceuticals, Inc.
3208 Red River
Suite 300
Austin, TX 78705 / US
02 / DONOVAN, Martin
c/o Xeris Phrmaceuticals, Inc.
3208 Red River
Suite 300
Austin, TX 78705 / US
 [2019/03]
Former [2016/50]01 / PRESTRELSKI, Steven
c/o Xeris Phrmaceuticals Inc.
3208 Red River
Suite 300
Austin, TX 78705 / US
02 / DONOVAN, Martin
c/o Xeris Phrmaceuticals Inc.
3208 Red River
Suite 300
Austin, TX 78705 / US
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[2016/50]
Application number, filing date15706976.606.02.2015
[2016/50]
WO2015US14756
Priority number, dateUS201461936675P06.02.2014         Original published format: US 201461936675 P
[2016/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015120231
Date:13.08.2015
Language:EN
[2015/32]
Type: A2 Application without search report 
No.:EP3102184
Date:14.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 13.08.2015 takes the place of the publication of the European patent application.
[2016/50]
Type: B1 Patent specification 
No.:EP3102184
Date:30.01.2019
Language:EN
[2019/05]
Search report(s)International search report - published on:EP23.12.2015
ClassificationIPC:A61K9/08, A61K9/19, A61K47/02, A61K47/20, A61K38/26, A61P5/48
[2018/39]
CPC:
A61K38/26 (EP,CN,KR,US); A61K9/0019 (EP,CN,KR,US); A61K38/09 (EP,CN,KR,US);
A61K38/22 (EP,US); A61K38/25 (EP,CN,KR,US); A61K38/28 (EP,CN,KR,US);
A61K38/30 (EP,CN,KR,US); A61K38/4893 (EP,CN,KR,US); A61K47/02 (EP,CN,KR,US);
A61K47/20 (EP,CN,KR,US); A61K47/26 (US); A61K9/19 (EP,CN,KR,US);
A61P3/00 (EP); A61P3/08 (EP); A61P3/10 (EP);
A61P5/48 (EP) (-)
Former IPC [2016/50]A61K9/08, A61K9/19, A61K47/02, A61K47/20, A61K38/22, A61P5/48
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/50]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:STABILE PEPTIDFORMULIERUNGEN UND VERFAHREN ZUR HERSTELLUNG[2016/50]
English:STABLE PEPTIDE FORMULATIONS AND METHODS FOR PREPARATION[2016/50]
French:FORMULATIONS STABLES DE PEPTIDES ET LEURS PROCÉDÉS DE PRÉPARATION[2016/50]
Entry into regional phase05.09.2016National basic fee paid 
05.09.2016Designation fee(s) paid 
05.09.2016Examination fee paid 
Examination procedure05.09.2016Examination requested  [2016/50]
05.09.2016Date on which the examining division has become responsible
24.03.2017Amendment by applicant (claims and/or description)
08.03.2018Despatch of a communication from the examining division (Time limit: M04)
18.07.2018Reply to a communication from the examining division
10.09.2018Communication of intention to grant the patent
10.12.2018Fee for grant paid
10.12.2018Fee for publishing/printing paid
10.12.2018Receipt of the translation of the claim(s)
Opposition(s)31.10.2019No opposition filed within time limit [2020/02]
Fees paidRenewal fee
10.02.2017Renewal fee patent year 03
14.02.2018Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.02.2015
AL30.01.2019
CY30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
MK30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
TR30.01.2019
LU06.02.2019
MT06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
[2022/31]
Former [2021/32]HU06.02.2015
AL30.01.2019
CY30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
TR30.01.2019
LU06.02.2019
MT06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2021/26]AL30.01.2019
CY30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
TR30.01.2019
LU06.02.2019
MT06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2020/29]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
TR30.01.2019
LU06.02.2019
MT06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2020/17]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
TR30.01.2019
LU06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2020/12]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SI30.01.2019
SK30.01.2019
SM30.01.2019
LU06.02.2019
BE28.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2020/04]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SK30.01.2019
SM30.01.2019
LU06.02.2019
CH28.02.2019
LI28.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/51]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SK30.01.2019
SM30.01.2019
LU06.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/49]AL30.01.2019
CZ30.01.2019
EE30.01.2019
ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RO30.01.2019
RS30.01.2019
SK30.01.2019
LU06.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/47]ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RS30.01.2019
LU06.02.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/46]ES30.01.2019
FI30.01.2019
HR30.01.2019
IT30.01.2019
LT30.01.2019
LV30.01.2019
MC30.01.2019
PL30.01.2019
RS30.01.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/39]ES30.01.2019
FI30.01.2019
HR30.01.2019
LT30.01.2019
LV30.01.2019
PL30.01.2019
RS30.01.2019
BG30.04.2019
GR01.05.2019
IS30.05.2019
PT30.05.2019
Former [2019/38]ES30.01.2019
FI30.01.2019
LT30.01.2019
PL30.01.2019
BG30.04.2019
GR01.05.2019
PT30.05.2019
Former [2019/37]ES30.01.2019
FI30.01.2019
LT30.01.2019
PL30.01.2019
GR01.05.2019
PT30.05.2019
Former [2019/35]ES30.01.2019
FI30.01.2019
LT30.01.2019
PL30.01.2019
PT30.05.2019
Former [2019/33]FI30.01.2019
LT30.01.2019
PT30.05.2019
Cited inInternational search[XI]US2012232001  (PRESTRELSKI STEVEN [US], et al) [X] 1-7,10,12-43,50-53 * the whole document * [I] 8,9,11;
 [XI]EP2526996  (XERIS PHARMACEUTICALS INC [US]) [X] 1-7,12-43,50-52 * examples 1-2 *[I] 8-11;
 [XI]WO2013067022  (XERIS PHARMACEUTICALS INC [US]) [X] 1-7,12-43,50,51,53 * the whole document * [I] 8-11
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.